+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colorectal Cancer Screening & Diagnostic Market by Type, Product, Application, End User - Global Forecast to 2030- Product Image
Colorectal Cancer Screening & Diagnostic Market by Type, Product, Application, End User - Global Forecast to 2030- Product Image
Sale

Colorectal Cancer Screening & Diagnostic Market by Type, Product, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925069
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Colorectal Cancer Screening & Diagnostic Market grew from USD 1.86 billion in 2024 to USD 1.99 billion in 2025. It is expected to continue growing at a CAGR of 7.41%, reaching USD 2.86 billion by 2030.

Setting the Stage for Next-Generation Colorectal Cancer Screening

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, underscoring the urgent need for early detection and effective diagnostic pathways. Recent advances in screening modalities and growing public awareness have resulted in increased adoption of routine testing, yet significant gaps in access, technology adoption, and care delivery persist. Health systems, policy makers, and industry stakeholders are all grappling with how to deploy emerging tools-while managing cost pressures and regulatory shifts-to maximize population health impact. This executive summary provides a strategic lens on the current landscape, distilling critical trends, segment-level drivers, regional nuances, competitive dynamics, and actionable recommendations. By synthesizing the latest data and expert insights, it enables decision-makers to align investments, partnerships, and innovation efforts with long-term clinical and commercial objectives.

Emerging Forces Reshaping Colorectal Cancer Detection

The colorectal cancer screening and diagnostic space is undergoing a metamorphosis driven by breakthroughs in molecular biology, digital health integration, and shifting reimbursement models. Non-invasive stool DNA assays and highly sensitive immunochemical tests are expanding access beyond traditional colonoscopy settings, enabling primary care providers and outpatient laboratories to play a larger role in early detection. Artificial intelligence and advanced imaging algorithms are augmenting clinician accuracy during endoscopic procedures, reducing missed lesions and standardizing reporting across heterogeneous care environments. Policy drivers, including updated screening guidelines advocating earlier and more frequent interventions, are amplifying demand for diversified test portfolios. Additionally, payers are increasingly tying reimbursement to quality metrics and patient outcomes, creating incentives for bundled service offerings. This confluence of technological maturation, regulatory refinement, and value-based care mandates is rewriting the rules for market participation and creating fertile ground for novel alliances across diagnostics, device, and data analytics firms.

Assessing the 2025 U.S. Tariff Shifts on Diagnostic Technologies

The introduction of new U.S. tariffs on imported medical equipment and diagnostic reagents in 2025 has triggered a ripple effect across the colorectal screening ecosystem. Devices such as colonoscopes, computerized tomography scanners, and specialized endoscopes have become subject to increased duty burdens, elevating capital expenditure requirements for hospitals and ambulatory surgical centers. At the same time, consumables-ranging from stool testing kits to reagents used in molecular assays-face steeper landed costs, challenging lab operators to maintain competitive pricing. Many global manufacturers are evaluating nearshoring of production facilities or renegotiating supplier contracts to mitigate margin erosion. These strategic adjustments are prompting downstream providers to reconsider procurement models, shift toward bundled service agreements, and invest in cost-containment technologies. As a result, the supply chain is experiencing heightened collaboration between device makers, reagent suppliers, and service providers to preserve throughput and ensure uninterrupted patient access despite escalating tariffs.

Dissecting Market Segments to Uncover Growth Drivers

Analyzing market segmentation illuminates the distinct growth trajectories within colorectal cancer screening. When dissecting type, imaging tests such as colonoscopy and CT colonography dominate clinical practice given their direct visualization capabilities, even as stool-based approaches gain traction for initial triage and population-level outreach. Within product segmentation, consumables like kits and reagents drive recurring revenue and capture high-volume workflows in central laboratories, whereas instruments such as endoscopes and CT scanners represent strategic capital investments influenced by hospital and ambulatory center budgets. Application-focused insights reveal early detection remains the primary revenue engine, but there is a growing emphasis on disease monitoring to track recurrence and prognosis assessment tools that guide therapeutic decisions. From an end-user perspective, hospitals continue to house the majority of advanced screening procedures, while diagnostics laboratories expand their role in decentralized testing and ambulatory surgical centers attract patients seeking less invasive, more convenient options; research institutes contribute by pioneering next-generation assays that ultimately transition to mainstream care.

Regional Nuances Charting the Future of Screening Adoption

Regional dynamics are instrumental in shaping the trajectory of colorectal cancer screening adoption. In the Americas, well-established reimbursement frameworks and widespread insurance coverage support high penetration of both invasive and non-invasive screening modalities, driving demand for advanced imaging and DNA-based stool tests in urban centers. Europe, Middle East & Africa presents a more heterogeneous picture: Western Europe leverages centralized health systems to negotiate favorable procurement terms for high-value instruments and reagents, while emerging markets in the Middle East and North Africa focus on scaling basic immunochemical screening programs to broaden early detection. In the Asia-Pacific region, rapid urbanization and increasing healthcare expenditure are fueling investments in diagnostic infrastructure; countries like Japan and Australia are early adopters of AI-enhanced endoscopy, whereas Southeast Asian nations are prioritizing cost-effective stool testing to expand reach to underserved populations. Understanding these regional nuances is critical for designing market entry strategies and localizing value propositions.

Competitive Dynamics Among Leading Screening Industry Players

Competitive landscapes in colorectal cancer screening and diagnostics are defined by a mix of large diversified device and reagent manufacturers, specialist molecular diagnostics firms, and emerging digital health innovators. Leading device companies are differentiating through integrated platforms that couple advanced imaging hardware with AI-driven analytics, forging partnerships with software providers to deliver end-to-end procedural support. Meanwhile, molecular diagnostics pioneers are expanding their stool DNA and immunochemical test portfolios, leveraging high-throughput processing capabilities and proprietary biomarkers to enhance sensitivity. Strategic alliances and M&A activity are prevalent as incumbents seek to fill portfolio gaps-be it in non-invasive testing or data management solutions-and gain access to new distribution channels. Smaller, agile entrants are carving niches in the early detection and prognosis assessment segments, often collaborating with research institutions to validate novel markers and secure regulatory clearance. This multi-tiered competitive environment underscores the importance of both scale and innovation agility in maintaining market leadership.

Strategic Imperatives for Advancing Screening and Diagnostics

Industry leaders must adopt a multi-pronged approach to secure long-term advantage. First, prioritizing investment in AI and machine learning solutions can enhance diagnostic accuracy and differentiate service offerings. Second, expanding non-invasive test channels through primary care integration and direct-to-consumer outreach will broaden screening coverage and reduce reliance on high-cost procedural settings. Third, forging collaborative agreements with payers and health systems to develop value-based contracting models will align incentives around quality outcomes and secure premium reimbursement. Fourth, tailoring market strategies by region-whether negotiating bulk procurement in Europe’s centralized systems or partnering with local distributors in emerging Asia-Pacific markets-will optimize resource allocation. Finally, reinforcing supply chain resilience through diversified sourcing and flexible manufacturing footprints can mitigate the impact of geopolitical shifts and tariff fluctuations. By executing these recommendations in concert, organizations can navigate complexity and deliver measurable clinical and commercial returns.

Rigorous Approach to Data Collection and Analysis Methodology

This report’s findings are grounded in a rigorous methodology that synthesizes primary and secondary research. Quantitative data were extracted from public filings, government and regulatory databases, peer-reviewed journals, and proprietary industry surveys. In-depth interviews with key opinion leaders, clinical experts, procurement directors, and C-suite executives provided qualitative context around adoption barriers, technological preferences, and competitive positioning. Data triangulation techniques were applied to validate disparate sources and ensure consistency. Market participants were profiled based on financial performance, product portfolio breadth, geographic reach, and innovation pipelines. All insights underwent multiple rounds of editorial review and accuracy checks to uphold analytical integrity. This robust research framework underpins the strategic recommendations and insights presented throughout the executive summary.

Key Conclusions Guiding Stakeholder Decisions in Screening

The convergence of innovative diagnostics, evolving policy landscape, and shifting patient expectations is redefining colorectal cancer screening. Key themes emerge: non-invasive tests are unlocking new patient cohorts, AI-enabled imaging is raising the bar for clinical performance, and regional variations demand tailored market approaches. Simultaneously, manufacturers and providers must navigate tariff-induced cost pressures, complex reimbursement environments, and intensifying competition. By focusing on segmented growth drivers, regional priorities, and collaborative ecosystems, stakeholders can translate these challenges into opportunities-ultimately driving earlier detection, optimizing resource utilization, and improving patient outcomes. The insights and recommendations detailed in this summary offer a strategic roadmap for organizations committed to leadership in colorectal cancer screening and diagnostics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Screening Tests
      • Blood Tests
      • Imaging Tests
        • Colonoscopy
        • CT Colonography
        • Flexible Sigmoidoscopy
    • Stool Tests
      • Fecal Immunochemical Test
      • Guaiac-Based Fecal Occult Blood Test
      • Multitarget Stool DNA Testing
  • Product
    • Consumables
      • Kits
      • Reagents
    • Instruments
      • CT Scanners
      • Endoscopes
  • Application
    • Disease Monitoring
    • Early Detection
    • Prognosis Assessment
  • End User
    • Ambulatory Surgical Centers
    • Diagnostics Laboratories
    • Hospitals
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bristol-Myers Squibb Company
  • Clinical Genomics Technologies Pty Ltd.
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Novartis AG
  • Novigenix SA
  • Olympus Corporation
  • Prenetics Global Limited
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Colorectal Cancer Screening & Diagnostic Market, by Type
8.1. Introduction
8.2. Screening Tests
8.2.1. Blood Tests
8.2.2. Imaging Tests
8.2.2.1. Colonoscopy
8.2.2.2. CT Colonography
8.2.2.3. Flexible Sigmoidoscopy
8.3. Stool Tests
8.3.1. Fecal Immunochemical Test
8.3.2. Guaiac-Based Fecal Occult Blood Test
8.3.3. Multitarget Stool DNA Testing
9. Colorectal Cancer Screening & Diagnostic Market, by Product
9.1. Introduction
9.2. Consumables
9.2.1. Kits
9.2.2. Reagents
9.3. Instruments
9.3.1. CT Scanners
9.3.2. Endoscopes
10. Colorectal Cancer Screening & Diagnostic Market, by Application
10.1. Introduction
10.2. Disease Monitoring
10.3. Early Detection
10.4. Prognosis Assessment
11. Colorectal Cancer Screening & Diagnostic Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Diagnostics Laboratories
11.4. Hospitals
11.5. Research Institutes
12. Americas Colorectal Cancer Screening & Diagnostic Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Colorectal Cancer Screening & Diagnostic Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Colorectal Cancer Screening & Diagnostic Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. AbbVie Inc.
15.3.3. Agilent Technologies, Inc.
15.3.4. Bayer AG
15.3.5. Becton, Dickinson and Company
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. bioMérieux SA
15.3.8. Bristol-Myers Squibb Company
15.3.9. Clinical Genomics Technologies Pty Ltd.
15.3.10. Eiken Chemical Co., Ltd.
15.3.11. Epigenomics AG
15.3.12. Exact Sciences Corp.
15.3.13. F. Hoffmann-La Roche Ltd.
15.3.14. Fujifilm Holdings Corporation
15.3.15. GE HealthCare Technologies, Inc.
15.3.16. Guardant Health, Inc.
15.3.17. Hologic, Inc.
15.3.18. Illumina, Inc.
15.3.19. KARL STORZ SE & Co. KG
15.3.20. Medtronic PLC
15.3.21. Merck KGaA
15.3.22. Myriad Genetics, Inc.
15.3.23. Novartis AG
15.3.24. Novigenix SA
15.3.25. Olympus Corporation
15.3.26. Prenetics Global Limited
15.3.27. QIAGEN N.V.
15.3.28. Quest Diagnostics Incorporated
15.3.29. Sanofi SA
15.3.30. Siemens AG
15.3.31. Sysmex Corporation
15.3.32. Thermo Fisher Scientific Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET MULTI-CURRENCY
FIGURE 2. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET MULTI-LANGUAGE
FIGURE 3. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CT COLONOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY FECAL IMMUNOCHEMICAL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY GUAIAC-BASED FECAL OCCULT BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY MULTITARGET STOOL DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PROGNOSIS ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 60. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 61. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 62. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 65. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 115. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 116. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 117. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 119. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 125. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 142. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 143. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 144. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 146. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 147. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 151. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 152. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 153. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 155. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 187. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 188. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 189. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 191. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 205. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 206. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 207. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 209. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 210. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 214. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 215. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 216. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 218. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 242. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 243. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 245. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 250. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 251. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 252. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 254. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 268. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 269. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 270. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 272. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 277. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 278. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 279. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 281. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 282. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MIL

Companies Mentioned

The companies profiled in this Colorectal Cancer Screening & Diagnostic market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bristol-Myers Squibb Company
  • Clinical Genomics Technologies Pty Ltd.
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Novartis AG
  • Novigenix SA
  • Olympus Corporation
  • Prenetics Global Limited
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.86 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Colorectal Cancer Screening and Diagnostics Market - Product Image

Colorectal Cancer Screening and Diagnostics Market

  • Report
  • 166 Pages
  • Global
From
Colorectal Cancer Screening Market Report 2025 - Product Image

Colorectal Cancer Screening Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 159 Pages
  • Global
From
Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.